pertuzumab,trastuzumab
roche
['perelisa']
reveal genomics, s.l.:esmo 2022: reveal genomics presents new validation data of her2dx in the perelisa trial 
PRpro is a @BelgaNewsAgency service for communication professionals #PressRelease #MediaMonitoring #BelgaAgenda #BelgaImage